In order to establish a system for structural studies of the murine class I major histocompatibility antigen complex (MHC) H-2K d , a bacterial expression system and in vitro refolding preparation of the complex of H-2K d with human 2 m and the immunodominant peptide SYVNTNMGL from hepatitis B virus (HBV) core-protein residues 87±95 was employed. The complex (45 kDa) was crystallized; the crystals belong to space group P222 1 , with unit-cell parameters a = 89.082, b = 110.398, c = 47.015 A Ê , = = = 90
In order to establish a system for structural studies of the murine class I major histocompatibility antigen complex (MHC) H-2K d , a bacterial expression system and in vitro refolding preparation of the complex of H-2K d with human 2 m and the immunodominant peptide SYVNTNMGL from hepatitis B virus (HBV) core-protein residues 87±95 was employed. The complex (45 kDa) was crystallized; the crystals belong to space group P222 1 , with unit-cell parameters a = 89.082, b = 110.398, c = 47.015 A Ê , = = = 90
. The crystals contain one complex per asymmetric unit and diffract X-rays to at least 2.06 A Ê resolution. The structure has been solved by molecular replacement and is the ®rst crystal structure of a peptide± H-2K d complex.
Introduction
Major histocompatibility complex (MHC) class I molecules (MHC-I) are plasma-membrane proteins that are expressed by virtually all mammalian cells and play a central role in cellular immune recognition. They present short segments (peptides) of intracellularly processed proteins (forming a peptide±MHC-I complex, abbreviated pMHC-I) to the T-cell receptors (TCR) of cytotoxic T lymphocytes (CTL). This type of speci®c selective recognition triggers T-cell activation through TCR signal transduction, leading to the CTL cell killing of infected cells (Zinkernagel & Doherty, 1974; Haskins et al., 1984; Townsend et al., 1986; Bjorkman & Parham, 1990) , thus conferring cellular immunity against viral infection. pMHC-I molecules are heterotrimeric structures with (i) a polymorphic membraneanchored heavy chain with extracellular domains 1 , 2 and 3 , (ii) a light invariant soluble noncovalently attached 2 -microglobulin ( 2 m) unit and (iii) an 8±11-aminoacid peptide positioned in a cleft formed by the 1 and 2 domains of the heavy chain (Madden, 1995) .
MHC class I genes are characterized by their extraordinary polymorphism, being the most polymorphic genes known to date, which imparts unique spatial and chemical characteristics to each cleft (Trowsdale & Campbell, 1992) and in turn dictates the T-cell epitopes (the binding peptides) of each MHC class I allele. Human HLA-A2 (A*0201) was the ®rst crystal structure of an MHC complex to be determined (Bjorkman et al. 1987a,b) and was soon followed by the structures of murine and human MHC molecules complexed with single peptides (reviewed in Madden, 1995; Jones, 1997) . Analysis of these structures improved our comprehension of how cleft architecture affects both peptide presentation and the conformation of the side chains situated on the 1 and 2 helices bordering the binding cleft.
The purpose of the present study was to establish a system for structural studies of the murine MHC class I H-2K (Falk et al., 1991; Maryanski et al., 1993) . The H-2K d molecule has been widely used in functional analysis of T-cell recognition and its epitopes include not only many foreign antigens but also autologous antigens (Amrani et al., 2000; Fan et al., 2000) ; therefore, analysis of the H-2K d molecular structure will help in understanding the detail of antigen presentation in cellular immunity and the mechanism of autoimmune disorder. Secondly, HBV is a noncytopathic DNA virus that chronically infects 350 million people worldwide. Like many other chronic viral diseases and cancers, it is associated with T-cell hyper-responsiveness or tolerance (Chisari, 1995; Chisari & Ferrari, 1995) . HBV transgenic mice have already become a model system for the evaluation of immunotherapeutic strategies to break tolerance and terminate persistent HBV infection (Chisari, 1995) . Mutation within immunodominant CTL epitopes is closely connected with immunological tolerance (McMichael, 1993; Bertoletti et al., 1994) . Therefore, structural knowledge of the complex of H-2K d with HBV core 87±96, which is an immunodominant epitope of HBV major antigen, will be of bene®t to research on the structural mechanism of immunological tolerance. Thirdly, we have previously found that a 7-mer peptide (YVNTNMG) of the HBV-core antigen (HBcAg 88±94) is associated with heat-shock protein (HSP) gp96 in liver tissues of patients with HBV-induced hepatocellular carcinoma (HCC; Meng et al., 2001 Meng et al., , 2002 . This peptide is highly homologous to mouse H-2K d -restricted 9-mer peptide (SYVNTNMGL; core 87±95). We have also found that this 7-mer binds to H-2K d in vitro (unpublished data), though with a lower af®nity than the 9-mer peptide.
We have employed a bacterial expression system and in vitro complex assembly to prepare crystals of H-2K d with the peptide SYVNTNMGL from HBV core-protein residues 87±95. This H-2K d -restricted peptide has been shown to elicit CTL responses in H-2 d mice with DNA vaccination (Kuhrober et al., 1997). We report here the conditions for successful refolding, puri®cation and crystallization of the complex of H-2K d with this HBV-core 87±95 epitope. The crystals diffract X-rays to beyond 2.06 A Ê and the structure has been solved by molecular replacement.
Materials and methods

Preparation of H-2K d and b 2 m proteins as inclusion bodies
To construct the expression vector of H-2K d heavy chain and 2 m, the region encoding amino acids 1±280 of H-2K d heavy chain and amino acids 1±99 of human 2 m were ampli®ed by PCR and cloned into pET-3a. The expression plasmids were veri®ed by sequencing and transformed into BL21(DE3)pLysS (Novagen). Transformed BL21(DE3)pLysS cells were grown at 310 K in Luria±Bertani medium containing 50 mg ml À1 carbenicillin. Isopropyl-d-thiogalactopyranoside (IPTG; Sigma) was added to a ®nal concentration of 0.5 mM when the culture reached an OD 600 of 0.6. After a further 3±4 h incubation at 310 K, the bacteria were harvested and suspended in cold phosphate-buffered saline (PBS) buffer. After being lysed using a sonicator and centrifuged at 20 000g, the pellet was washed three times with a solution of 20 mM Tris±HCl, 100 mM NaCl, 1 mM EDTA, 1 mM DTT and 0.5% Triton X-100. H-2K d and 2 m inclusion bodies constituted most of the pellet.
Preparation of the H-2K d complex
This was carried out essentially as previously described by Wiley and coworkers (Garboczi et al., 1992) . Brie¯y, the H-2K d heavy chain and 2 m inclusion bodies were separately dissolved in a solution of 10 mM Tris±HCl pH 8.0 and 8 M urea. The synthetically prepared HBV-derived peptide (SYVNTNMGL) was also dissolved in dimethyl sulfoxide (DMSO). H-2K d heavy chain, 2 m and peptide in a 1:1:3 molar ratio were refolded by dilution. After 24±48 h of incubation at 277 K, the soluble portion was concentrated and then puri®ed by chromatography on a Superdex G-75 (Pharmacia) size-exclusion column followed by Mono Q (Pharmacia) anion-exchange chromatography.
Crystallization of the H-2K d complex
The puri®ed complex protein (45 kDa) was dialyzed against crystallization buffer (10 mM Tris±HCl pH 8.0, 10 mM NaCl) and concentrated to 10 mg ml À1 . Initial crystallization conditions were screened using Crystal Screen (Hampton Research). The complex crystallized from conditions containing PEG 20 000. The conditions yielding crystals were further optimized by variation of precipitant and protein concentration and additives. Crystals of good quality can be obtained using 0.1 M MES pH 6.5, 18%(w/v) PEG 20 000, 8%(v/v) DMSO. Crystallization was performed by the hanging-drop vapourdiffusion method at 291 K. 1 ml protein solution was mixed with 1 ml reservoir solution and the mixture was equilibrated against 200 ml reservoir solution at 291 K.
Data collection and processing
Data collection from the H-2K
d complex was performed in-house on a Rigaku RU-2000 rotating copper-anode X-ray generator operated at 48 kV and 98 mA (Cu K; ! = 1.5418 A Ê ) with a MAR 345 image-plate detector. The crystals were mounted in nylon loops and¯ash-cooled in a cold nitrogen-gas stream at 100 K using an Oxford Cryosystem with reservoir solution as the cryoprotectant. Data were indexed and scaled using DENZO and SCALE-PACK (Otwinowski & Minor, 1997).
Results and discussion
H-2K
d heavy chain could only be refolded in the presence of 2 m and peptide (Figs. 1a, 1b  and 1c) . The refolding resulted in yields of approximately 10% of complex (45 kDa), which could be puri®ed to homogeneity by Superdex G-75 size-exclusion chromatography and Mono Q (Pharmacia) anionexchange chromatography (Figs. 1a, 1b and  1c) . The chromatographic elution pro®le showed three peaks corresponding to the refolded complex (45 kDa; peak 2), uncomplexed 2 m (peak 3) and non-native aggregated products (peak 1; Figs. 1a and  1b) . The refolded complex was further puri®ed by Mono Q chromatography and the complex was eluted at an NaCl concentration of 17±26 mM (Fig. 1c) . Moreover, we . Assuming the presence of one molecule in the asymmetric unit, the solvent content is calculated to be about 56%. Selected data statistics are shown in Table 1 . Structure determination by molecular replacement using the structure of a murine H-2D b complex (PDB code 1fg2; Tissot et al., 2000) as a search model has been successful and the detailed structure will be reported elsewhere. Typical crystals of the H-2K d ±HBV core 87±95 complex, which were used for data collection. 
